Dexmedetomidine
Dexmedetomidine, sold under the trade name Precedex among others, is a drug used in humans for sedation. Veterinarians use dexmedetomidine for similar purposes in treating cats, dogs, and horses. It is also used in humans to treat acute agitation associated with schizophrenia or bipolar I or II disorder.
Clinical data | |
---|---|
Trade names | Precedex, Dexdor, Igalmi, others |
AHFS/Drugs.com | Monograph |
License data |
|
Pregnancy category |
|
Routes of administration | Intravenous, transmucosal, intranasal, sublingual |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Protein binding | 94% (mostly albumin) |
Metabolism | Near complete hepatic metabolism to inactive metabolites |
Elimination half-life | 2–4 hours |
Excretion | Urine |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.119.391 |
Chemical and physical data | |
Formula | C13H16N2 |
Molar mass | 200.285 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Similar to clonidine, it is a sympatholytic drug that acts as an agonist of α2-adrenergic receptors in certain parts of the brain. It was developed by Orion Pharma.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.